Physician profile
Line Jacques
NPI 1083016091
$31,571.04
in general payments reported to CMS, 2019-2025
9 companies · $466 in 2025
The $466 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $860 · 2021: $4,948 · 2022: $391 · 2023: $223 · 2024: $450 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,138.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,209.07 | 2019-2023 | Proclaim |
| Axogen | $10,369.92 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Medtronic USA, INC. | $254.62 | 2019 | |
| Stryker Corporation | $203.89 | 2019 | |
| Medtronic, INC. | $192.44 | 2024-2025 | Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $112.80 | 2019 | |
| Nevro Corp. | $107.16 | 2022-2024 | Senza |
| Integra Lifesciences Corporation | $102.94 | 2021 | |
| Springworks Therapeutics, INC. | $18.20 | 2025 | Gomekli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Line Jacques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.